The effects of phenobarbital and diazepam on cell proliferation and neurogenesis were studied in newborn rats followed for 6 months, in a study at University of Dresden, Germany; Medical University, Lublin, Poland; University Medicine Berlin, Germany; and Solvay Research Laboratories, Weesp, The Netherlands. The N-methyl-D-aspartate antagonist MK801, and the GABA subtype A agonists phenobarbital and diazepam administered to infant rats on postnatal days 6-10 caused reduced numbers of neurons in the hippocampal dentate gyrus at postnatal day 15. No apoptosis was demonstrated. At age 6 months, phenobarbital-treated rats had fewer neurons in the dentate gyrus and performed worse than saline-treated littermates in water maze learning and memory task. 
COMMENT. Neurogenesis in the hippocampal dentate gyms is at its peak during the first week of postnatal life and declines progressively after day 9 in newborn rats. Phenobarbital administered in the first week to 10 days results in reduced neurogenesis at 2 weeks postnatally and impairment of learning and memory at 6 months, equivalent to adult life. These effects result in decreased hippocampal volume, reduced neuronal densities in the dentate gyms, the CA1-hippocampus, and the cingulate cortex. These observations call for caution regarding the use of NMDA receptor antagonists and GABA-a agonists in neonatal, pediatric, and obstetric medicine.
SLEEP DISORDERS SLEEP TERRORS IN TWINS
In an attempt to clarify the genetic and environmental causes of sleep terrors in childhood, reasearchers in Canada followed 390 pairs of monozygotic and dizygotic twins by assessing the frequency of sleep terrors at 18 and 30 months of age using a questionnaire administered to the biological mothers. 
